Stomach cancer, also known as gastric cancer, is the fourth-highest cause of cancer deaths worldwide, and 17th-most common ...

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, ...

The Moonshot program was the largest, organized effort by the U.S. government to find cancer cures. Congress voted it down.

What if we could eliminate a major risk factor for stomach cancer in Black, Asian, Latino and other vulnerable populations? A ...

and MAINZ, Germany, May 07, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ), a molecular genetics diagnostic company ...

A Chinese woman's routine medical exam revealed a hidden testicle, prompting doctors to diagnose her with a rare genetic ...

Despite significant progress in treating gastrointestinal (GI) cancers through surgical resection, chemotherapy, radiotherapy ...

The global stomach cancer treatment market was valued at $2.61 billion in 2018 and is expected to reach $20.92 billion by 2032, with a noteworthy compounding annual growth rate (CAGR) of 16% over ...

Mayo Clinic researchers used a new approach to chemotherapy to more than double the typical survival rate for patients with ...

Global HER2 Positive Gastric Cancer Industry is estimated at US$ 1261.8 Million in 2023 and US$ 1779.8 Million by 2033, at a ...

For certain patients with HER2-positive gastric cancers, a Keytruda treatment combination has shown promising survival outcomes.

Many of the early signs of stomach cancer, such as nausea or being sick, are common – and usually not due to cancer – but it's important to know when to talk to your GP Stomach cancer ...